Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Peter Sorger
Harvard Medical School, Department: Biology
Should you be removed from our database? Contact us at [email protected]. Read more below.
RareCyte, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Sorger will be performing experiments with RareCyte technologies but will not work on these technologies (or seeking to improve them) as part of the Center for Cancer Systems Pharmacology.
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
NARRATIVE Targeted drugs and, more recently, therapeutic antibodies that inhibit immune checkpoint regulators to augment the body?s own defenses against cancer, are among the most promising approaches to treating cancer. However, the majority of cancer patients derive no long-term benefit from such drugs and even those who do may suffer from serious adverse effects. Systematic study of therapeutic and adverse drug responses using diverse experimental technologies and the latest data science and machine learning methods is essential for bringing about the next wave of precision cancer medicine.
Filed on April 03, 2018.
Tell us what you know about Peter Sorger's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Peter Sorger filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $200,000 - $249,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $200,000 - $249,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $10,000 - $19,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | RareCyte | $10,000 - $19,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | RareCyte, Inc. | $10,000 - $19,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $10,000 - $19,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $0 - $4,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $0 - $4,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Glencoe Software | $0 - $4,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Glencoe Software | Value cannot be readily determined |
| Peter Sorger | Harvard Medical School | Conflict of Interest | RareCyte | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.